Jane Street Group, LLC Acasti Pharma Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.43 - $0.57 $6,112 - $8,103
14,216 New
14,216 $7,000
Q1 2022

May 17, 2022
SELL
$0.94 - $1.43 $17,298 - $26,316
-18,403 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$1.07 - $2.01 $552 - $1,037
-516 Reduced 2.73%
18,403 $23,000
Q3 2021

Nov 16, 2021
BUY
$1.96 - $4.72 $37,081 - $89,297
18,919 New
18,919 $38,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email